Witiak D T, Trivedi B K, Schmid F A
J Med Chem. 1985 Aug;28(8):1111-3. doi: 10.1021/jm00146a025.
Geometric isomers of 2,11-bis(morpholinomethyl)tetrahydrodipyrazino[1,2-a:2',1'-c]pyraz ine-1, 3,10,12-(2H,4H,9H,11H)-tetrone (3 and 4) and the parent bisimides (1 and 2) were studied for their stereoselective antimetastatic activity in the Lewis Lung carcinoma model. The morpholinomethyl cis-syn-trans isomer 4 was more effective as an inhibitor of metastasis than the other three analogues. Using a postamputation protocol, the order of decreasing activity was cis morpholinomethyl analogue 4 greater than trans morpholinomethyl analogue 3 greater than parent cis imide 2 greater than parent trans imide 1. Increased activity observed for the morpholinomethyl derivatives may reflect differences in solubility and delivery (prodrug) or an intrinsic antitumor activity of the morpholinomethyl-N functionality.
研究了2,11 - 双(吗啉甲基)四氢二吡嗪并[1,2 - a:2',1'- c]吡嗪 - 1,3,10,12 -(2H,4H,9H,11H)- 四酮(3和4)的几何异构体以及母体双酰亚胺(1和2)在Lewis肺癌模型中的立体选择性抗转移活性。吗啉甲基顺 - 顺 - 反异构体4作为转移抑制剂比其他三种类似物更有效。采用截肢后方案,活性降低的顺序为:顺式吗啉甲基类似物4>反式吗啉甲基类似物3>母体顺式酰亚胺2>母体反式酰亚胺1。吗啉甲基衍生物活性的增加可能反映了溶解度和递送(前药)的差异或吗啉甲基 - N官能团的内在抗肿瘤活性。